Intermede Investment Partners Ltd
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1664713
LONDON, X0
Position in VRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$50,477,205
+$2,978,746 QoQ
Shares Held
101,619
-4.5% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
4.65%
of 13F equity value
Holder Rank
#170
of 1,735 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Intermede Investment Partners Ltd holds $50,477,205 across 1 Biotechnology name. VRTX ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
101,619 | $50,477,205 |
All Filings in VRTX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $50,477,205 | 101,619 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $47,498,459 | 106,370 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $60,468,250 | 133,378 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $54,838,607 | 140,023 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $86,330,958 | 193,915 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $98,925,096 | 204,045 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||